OncoNano Medicine, Inc. today announced that Kartik Krishnan, M.D., Ph.D., has been promoted to the new role of President and Head of Research and Development. He has served as Chief Medical Officer since 2022
Company Information
Company
OncoNano Medicine
Location
3060 Pegasus Park Drive
Dallas, Texas, United States
About
OncoNano is harnessing the power of nanotechnology to unlock a new era of targeted therapeutics. Our ON-BOARD™ polymeric micelle platform exploits the highly acidic tumor microenvironment, a byproduct of cancer metabolism, to precisely deliver therapeutic payloads directly to the tumor site. OncoNano’s product candidates are designed to improve the pharmacokinetic and pharmacodynamic properties of various payloads from small molecules to large biologics through encapsulation and localized tumor targeting.
Fundz sees it the moment OncoNano Medicine changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
DallasBiotechnologyHealth CareMedicalTherapeutics